Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
Stocks in this Quantisnow insightTechnology
Historical context for TEM
Across the 23 sessions after earlier TEM headlines, the stock closed higher 12 times and lower 11 times, with a median move of 4.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TEM | SPY |
|---|---|---|---|
| Jun 9, 2026 | Genetics in Medicine Open Study Demonstrates How Ambry Genetics' ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing | +0.5% | -0.3% |
| Jun 8, 2026 | Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference | +4.7% | +0.2% |
| Jun 3, 2026 | Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members | -4.3% | -0.7% |
| Jun 2, 2026 | Wolfe Research resumed coverage on Tempus AI | -6.0% | +0.1% |
| Jun 1, 2026 | Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xHand 3 other headlines that session | +4.6% | +0.3% |
| May 29, 2026 | Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncologyand 1 other headline that session | -1.6% | +0.2% |
Quantisnow market dataNASDAQ
TEM
Tempus AI Inc.
- Market cap
- 30-day
- Sector
- Technology
- Industry
- Computer Software: Programming Data Processing
- Listed since
- 2024
Get push alerts for TEM
Full TEM profile on Quantisnow Follow TEM and get a push notification the moment its next story breaks.